Syndax Pharmaceuticals (SNDX) SEC Filings & 10K Form $13.73 +0.10 (+0.73%) (As of 09:58 AM ET) Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Recent Syndax Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView11/12/20246:05 AMSyndax Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/08/20249:52 AMSyndax Pharmaceuticals (Subject)WELLINGTON MANAGEMENT GROUP LLP (Filed by)Form SC 13G/A11/05/20243:02 PMSyndax Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/05/20243:03 PMSyndax Pharmaceuticals (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 10/18/202410:49 AMSTATE STREET CORP (Filed by)Syndax Pharmaceuticals (Subject)Form SC 13G/A06/17/20248:26 AMGoldan Keith A. (Reporting)Syndax Pharmaceuticals (Issuer)Form 4Statement of changes in beneficial ownership of securities 05/08/20246:03 AMSyndax Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/08/20246:04 AMSyndax Pharmaceuticals (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 03/18/20246:10 AMSyndax Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/27/20244:21 PMSyndax Pharmaceuticals (Filer)Form S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans 02/27/20244:28 PMSyndax Pharmaceuticals (Filer)Form S-3ASR02/27/20243:33 PMSyndax Pharmaceuticals (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 02/14/202411:50 AMKynam Capital Management, LP (Filed by)Syndax Pharmaceuticals (Subject)Form SC 13G02/14/20246:01 AMPoint72 Asset Management, L.P. (Filed by)Syndax Pharmaceuticals (Subject)Form SC 13G/A02/13/20248:44 PMAvidity Partners Management LP (Filed by)Syndax Pharmaceuticals (Subject)Form SC 13G/A02/08/20249:18 AMSyndax Pharmaceuticals (Subject)WELLINGTON MANAGEMENT GROUP LLP (Filed by)Form SC 13G/A01/25/202410:20 AMSTATE STREET CORP (Filed by)Syndax Pharmaceuticals (Subject)Form SC 13G/A12/20/20237:40 AMSyndax Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies ACLX SEC Filings ADMA SEC Filings APLS SEC Filings RARE SEC Filings BHVN SEC Filings IMVT SEC Filings SRRK SEC Filings OGN SEC Filings PTCT SEC Filings VRNA SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:SNDX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syndax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syndax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
